Cancer Detection and Diagnosis Research in Minnesota
Cancer Detection and Diagnosis Research (93.394) awarded $61.3 million to recipients in Minnesota in 43 grants from fiscal 2021 to 2025, 2.3% of the program's national total. Mayo Clinic received the most, $36.7 million.
- Awarded in Minnesota$61.3 million
- Awards43
- Share of the program2.3%
- Rank among states13th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 24 | $9.4 million |
| FY 2022 | 29 | $15.1 million |
| FY 2023 | 24 | $12.9 million |
| FY 2024 | 22 | $9.7 million |
| FY 2025 | 23 | $14.4 million |
Recipients in Minnesota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Mayo Clinic | Nonprofits | 22 | $36.7 million |
| Regents of the University of Minnesota | Colleges and universities | 18 | $20.7 million |
| Vergent Bioscience Inc | Small businesses | 1 | $2.0 million |
| Children's Health Care | Nonprofits | 1 | $1.5 million |
| Astrin Biosciences, Inc | Small businesses | 1 | $399,677 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Minnesota?
$61.3 million from fiscal 2021 to 2025, across 43 awards. Minnesota ranks 13th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Minnesota?
The largest recipient is Mayo Clinic, with $36.7 million in 22 awards. Next are Regents of the University of Minnesota and Vergent Bioscience Inc.
Can organizations in Minnesota apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Minnesota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Federal Transit Capital Investment Grants
- Special Education Grants to States
- Child Care and Development Block Grant
- Federal Transit Formula Grants
- Affordable Rural Cooperative